TALEN

TALEN1-cebpa

ID

ZDB-TALEN-150602-1

Name

TALEN1-cebpa

Previous Names

None

Target

cebpa (1)

Target Sequence 1

5' - CGAGGGAAATCCAAG - 3'

Target Sequence 2

5' - GTACTCGGTGCTGTT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

None

Genome Resources

None

Target Location

Constructs

No data available

Genomic Features

Genomic Feature	Affected Genomic Regions
rj31	cebpa

Expression

Gene expression in Wild Types + TALEN1-cebpa

No data available

Phenotype

Phenotype resulting from TALEN1-cebpa

No data available

Phenotype of all Fish created by or utilizing TALEN1-cebpa

Phenotype	Fish	Conditions	Figures
intrinsic apoptotic signaling pathway by p53 class mediator increased occurrence, abnormal	cebpa^rj31/rj31	standard conditions	Fig. 5 from Yuan et al., 2015
liver decreased size, abnormal	cebpa^rj31/rj31	standard conditions	Fig. 4 from Yan et al., 2022 Fig. 5 from Yuan et al., 2015
liver development process quality, abnormal	cebpa^rj31/rj31	standard conditions	Fig. 5 from Yuan et al., 2015
liver fabp1a expression decreased distribution, abnormal	cebpa^rj31/rj31	standard conditions	Fig. 5 from Yuan et al., 2015
liver apoptotic process increased process quality, abnormal	cebpa^rj31/+	standard conditions	Fig. 4 from Yuan et al., 2015
whole organism bcl2l1 expression increased amount, abnormal	cebpa^rj31/+	standard conditions	Fig. 5 from Yuan et al., 2015
whole organism mycb expression increased amount, abnormal	cebpa^rj31/+	standard conditions	Fig. 5 from Yuan et al., 2015
whole organism bcl2a expression increased amount, abnormal	cebpa^rj31/+	standard conditions	Fig. 5 from Yuan et al., 2015
liver cell population proliferation increased occurrence, abnormal	cebpa^rj31/+	standard conditions	Fig. 4 from Yuan et al., 2015
whole organism jun expression increased amount, abnormal	cebpa^rj31/+	standard conditions	Fig. 5 from Yuan et al., 2015
liver decreased size, abnormal	cebpa^rj31/+	standard conditions	Fig. 2 , Fig. S2 from Yuan et al., 2015
liver fabp1a expression decreased distribution, abnormal	cebpa^rj31/+	standard conditions	Fig. 2 , Fig. 5 , Fig. S2 from Yuan et al., 2015
liver fabp1a expression spatial pattern, ameliorated	cebpa^rj31/+ + MO7-tp53	standard conditions	Fig. 5 from Yuan et al., 2015
hematopoietic multipotent progenitor cell decreased amount, abnormal	cebpa^rj31/+ + MO1-sumo1 + MO1-sumo2b + MO1-sumo3a	standard conditions	Fig. 4 from Yuan et al., 2015
hematopoietic stem cell myb expression spatial pattern, ameliorated	dnmt1^rj794/rj794; cebpa^rj31/rj31	control	Fig. 6 from Liu et al., 2015
caudal hematopoietic tissue myb expression spatial pattern, ameliorated	dnmt1^rj794/rj794; cebpa^rj31/rj31	control	Fig. 6 from Liu et al., 2015
liver development process quality, ameliorated	tp53^zdf1/zdf1; cebpa^rj31/rj31	standard conditions	Fig. 5 from Yuan et al., 2015
liver size, ameliorated	tp53^zdf1/zdf1; cebpa^rj31/rj31	standard conditions	Fig. 5 from Yuan et al., 2015
liver fabp1a expression spatial pattern, ameliorated	tp53^zdf1/zdf1; cebpa^rj31/rj31	standard conditions	Fig. 5 from Yuan et al., 2015

Citations